Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
PaperCitations, authors & open-access status
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 139 citations, 2019 year and closed oa status.
139
Citations
2019
Year
closed
OA Status